Drugs / TRF-1101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00773890 | Jul 2008 → May 2009 | sickle cell disease | TRF Pharma, Inc | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TRF-1101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00773890 ↗ |
| Route | Oral | “300 mg orally” NCT00773890 ↗ |